Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel J. Becker Insider Profile
4 Followers
Daniel J. Becker, Director at Principia Biopharma, holds 3.00K shares in ACELYRIN, INC. (Ticker: SLRN), holds 5.00K shares in Day One Biopharmaceuticals (Ticker: DAWN), holds 0.00 shares in Pandion Therapeutics (Ticker: PAND). Most recently, Daniel J. Becker Sold ― shares of ACELYRIN, INC. on Jul 19, 2024 for an estimated value of 6.86.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+20.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel J. Becker holds in companies
Most Profitable Insider Trade
Stock:
Principia Biopharma
(PRNB)
(PRNB)
Rating:Informative Buy
Date:Oct 22, 2019 - Oct 22, 2020
Return:+222.40%
The most profitable trade made by Daniel J. Becker
Daniel J. Becker's Trading History
Principia Biopharma
Sep 28, 2020
―
Uninformative Sell
66.76M
$0.00
Pandion Therapeutics
Apr 01, 2021
―
Uninformative Sell
169.73M
$0.00
Day One Biopharmaceuticals
Jun 01, 2021
Director
Informative Buy
80.00K
$75.75K
ACELYRIN, INC.
Jul 19, 2024
Director
Informative Sell
6.86
$17.99K
List of latest transactions for each holding click on a transaction to see Daniel J. Becker's performance on stock
You May Also Like
Daniel J. Becker insider profile FAQ
What is the percentage of profitable transactions made by Daniel J. Becker?
The percentage of profitable transactions made by Daniel J. Becker is 60%.
What is the average return per transaction made by Daniel J. Becker?
The average return per transaction made by Daniel J. Becker is 20.60%.
What stocks does Daniel J. Becker hold?
Daniel J. Becker holds: PRNB, PAND, DAWN, SLRN stocks.
What was Daniel J. Becker’s latest transaction?
Daniel J. Becker latest transaction was an Informative Sell of $6.86.
What was Daniel J. Becker's most profitable transaction?
Daniel J. Becker’s most profitable transaction was an Informative Buy of PRNB stock on October 22, 2019. The return on the trade was 222.40%.
What is Daniel J. Becker's role in Principia Biopharma?
Daniel J. Becker's role in Principia Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.